DoxyPEP to Prevent Bacterial STIs-Ready for Prime Time?

Affiliations

Jeanne M Marrazzo et al. JAMA Intern Med. 2025.

. 2025 Mar 1;185(3):282-283.

doi: 10.1001/jamainternmed.2024.7165.

No abstract available

Comment in

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.
Sankaran M, Glidden DV, Kohn RP, Nguyen TQ, Bacon O, Buchbinder SP, Gandhi M, Havlir DV, Liebi C, Luetkemeyer AF, Nguyen JQ, Roman J, Scott H, Torres TS, Cohen SE. Sankaran M, et al. JAMA Intern Med. 2025 Mar 1;185(3):266-272. doi: 10.1001/jamainternmed.2024.7178. JAMA Intern Med. 2025. PMID: 39761052
Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis.
Traeger MW, Leyden WA, Volk JE, Silverberg MJ, Horberg MA, Davis TL, Mayer KH, Krakower DS, Young JG, Jenness SM, Marcus JL. Traeger MW, et al. JAMA Intern Med. 2025 Mar 1;185(3):273-281. doi: 10.1001/jamainternmed.2024.7186. JAMA Intern Med. 2025. PMID: 39761062 Free PMC article.
DoxyPEP Shows Promise for Reducing STIs in 2 Studies.
Anderer S. Anderer S. JAMA. 2025 Mar 4;333(9):746. doi: 10.1001/jama.2024.28812. JAMA. 2025. PMID: 39888626 No abstract available.